Prof. Heather Payne, Clinical Oncologist
Prof. Heather Payne
Clinical Oncologist
Prof. Heather Payne MBBS FRCP FRCR
Clinical Oncologist
Prof. Heather Payne
Clinical Oncologist MBBS FRCP FRCR
Areas of expertise
- Prostate cancer
- Novel hormone therapy
- External beam radiotherapy
- Chemotherapy
- Radiotherapy
Recommendations for Prof. Payne
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
-
The Prostate Centre
18 Devonshire St, Marylebone, London, W1G 7AQ
-
LOC at Chelsea
102 Sydney Street, Chelsea, London, SW3 6NJ
-
Telephone or video consultation
Virtual
About Prof. Heather Payne
GMC number: 2822301
Year qualified: 1983
Place of primary qualification: University of London
Initial consultation fees - £390
Follow up consultation fees - £280
Prof. Heather Payne is a consultant clinical oncologist, specialising in urological and prostate cancer at University College London Hospitals NHS Trust. She also sees patients privately at The Harley Street Clinic and The Prostate Centre.
Prof. Payne trained at St Mary’s Hospital and, after qualifying, spent time in general medicine in London and Haiti. Upon her return to London, she trained as a clinical oncologist and developed a keen interest in urological oncology.
In addition to her clinical work, Prof. Payne is actively involved in research. She has pioneered a programme of high-dose rate brachytherapy for prostate cancer. Her current research interests include hormone therapy, sensitisation of hormones and radiotherapy, predictive indices for bowel toxicity with radiotherapy, proton beam therapy for prostate cancer, chemotherapy, and assisting men with decision-making in prostate cancer.
Prof. Payne is the principal investigator in several international and national studies and has been published in peer-reviewed journals. She is the chair of the British Uro-oncology Group and the oncology lead for the National Prostate Cancer Audit. Additionally, she serves on the Prostate Cancer Advisory Group for the UK.
Her expertise includes a range of diseases, medical tests, and treatments such as external beam radiotherapy, intensity-modulated radiotherapy/rapid arc, low-dose brachytherapy, hormone treatment, novel hormone therapy, and chemotherapy. Prof. Payne has been with University College London Hospitals NHS Trust since her appointment and continues to contribute significantly to the field of oncology.
Areas of expertise
- Brachytherapy
- Chemotherapy
- External beam radiotherapy
- Hormone therapy
- Hormone treatment
- Image guided radiotherapy (IGRT)
- Intensity modulated radiotherapy/rapid arc
- Low does brachytherapy
- Novel hormone therapy
- Prostate cancer
- Radiotherapy
- Rapidarc or volume modulated arc therapy (VMAT)
Professional memberships
Articles by Prof. Heather Payne
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients